Publication No. 17‐05233‐EF‐1. Agency for Healthcare Research and Quality; 2018. https://www.ncbi.nlm.nih.gov/books/NBK525398/pdf/Bookshelf_NBK525398.pdf.18 18. Avenell A, Mak JC, O’Connell D. Vitamin D and vitamin D analogues for preventing fractures in postmenopausal women and older men. Cochrane Database Syst Rev. 2014;( 4):CD000227. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000227.pub4/epdf/full.
19 19. US Preventive Services Task Force. Final recommendation statement: Vitamin D, calcium, or combined supplementation for the primary prevention of fractures in community‐dwelling adults. 2018. https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/vitamin‐d‐calcium‐or‐combined‐supplementation‐for‐the‐primary‐prevention‐of‐fractures‐in‐adults‐preventive‐medication.
20 20. Schelke MW, Hackett K, Chen JL, et al. Isaacson RS. Nutritional interventions for Alzheimer's prevention: a clinical precision medicine approach. Ann N Y Acad Sci. 2016; 1367(1):50–6. doi: 10.1111/nyas.13070, https://nyaspubs.onlinelibrary.wiley.com/doi/epdf/10.1111/nyas.13070.
21 21. Morris MC, Nutrition and risk of dementia: overview and methodological issues. Ann N Y Acad Sci. 2016; 1367(1):31–7. doi: 10.1111/nyas.13047, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4849169/pdf/nihms765107.pdf.
22 22. McCleery J, Abraham RP, Denton DA, et al. Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment. Cochrane Database of Systematic Reviews. 2018, Issue 11. Art. No.: CD011905. DOI: 10.1002/14651858.CD011905.pub2, https://www.cochrane.org/CD011905/DEMENTIA_vitamin‐and‐mineral‐supplementation‐preventing‐dementia‐or‐delaying‐cognitive‐decline‐people‐mild.
23 23. Khoo HE, Ng HS, Yap WS, Goh HJH, Yim HS. Nutrients for prevention of macular degeneration and eye‐related diseases. Antioxidants (Basel). 2019; 8(4). pii: E85. doi: 10.3390/antiox8040085, https://www.mdpi.com/2076‐3921/8/4/85/htm.
24 24. Evans JR, Lawrenson JG. Antioxidant vitamin and mineral supplements for preventing age‐related macular degeneration. Cochrane Database of Systematic Reviews. 2017, Issue 7, Art. No.: CD000253, DOI: 27‐m10.1002/14651858.CD000253.pub4, https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000253.pub4/full.
25 25. Evans JR, Lawrenson JG. Antioxidant vitamin and mineral supplements for slowing the progression of age‐related macular degeneration. Cochrane Database of Systematic Reviews. 2017, Issue 7, Art. No.: CD000254. DOI: 10.1002/14651858.CD000254.pub4, https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000254.pub4/epdf/standard.
26 26. AREDS 2. PresserVision, Bausch + Lomb, https://www.preservision.com.
27 27. Mathew MC, Ervin AM, Tao J, Davis RM. Antioxidant vitamin supplementation for preventing and slowing the progression of age‐related cataract. Cochrane Database of Systematic Reviews. 2012, Issue 6. Art. No.: CD004567. DOI: 10.1002/14651858.CD004567.pub2.
28 28. Jiang H, Yin Y, Wu CR, et al. Dietary vitamin and carotenoid intake and risk of age‐related cataract. Am J Clin Nutr. 2019; 109(1):43–54. doi: 10.1093/ajcn/nqy270, https://www.ncbi.nlm.nih.gov/pubmed/30624584.
29 29. Age‐Related Eye Disease Study 2 (AREDS2) Research Group, Chew EY, SanGiovanni JP, Ferris FL, et al. Lutein/zeaxanthin for the treatment of age‐related cataract: AREDS2 randomized trial report no. 4. JAMA Ophthalmol. 2013; 131(7):843–50. doi: 10.1001/jamaophthalmol.2013.4412, https://www.ncbi.nlm.nih.gov/pubmed/23645227.
30 30. Rees K, Hartley L, Day C, Flowers N, Clarke A, Stranges S. Selenium supplementation for the primary prevention of cardiovascular disease. Cochrane Database of Systematic Reviews. 2013, Issue 1. Art. No.: CD009671. DOI: 10.1002/14651858.CD009671.pub2, https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009671.pub2/epdf/full.
31 31. Cai, X, Wang C, Yu Wanqui, et al. Selenium exposure and cancer risk: an updated meta‐analysis and meta‐regression. Sci Rep. 2016; 6;19213; doi: 10.1038/srep19213, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4726178.
32 32. Vinceti M, Filippini T, Del Giovane C, et al. Selenium for preventing cancer. Cochrane Database of Systematic Reviews. 2018, Issue 1. Art. No.: CD005195. DOI: 10.1002/14651858.CD005195.pub4, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491296/pdf/CD005195.pdf.
33 33. Fortmann SP, Burda BU, Senger CA, Lin J, Beil T, O’Connor E, Whitlock EP. Vitamin, mineral, and multivitamin supplements for the primary prevention of cardiovascular disease and cancer: a systematic evidence review for the US Preventive Services Task Force. Multivitamins for the prevention of CVD and cancer, Kaiser Permanente Research Affiliates EPC Evidence Report No. 108. AHRQ Publication No. 14‐05199‐EF‐1. Agency for Healthcare Research and Quality, 2013, https://www.ncbi.nlm.nih.gov/books/NBK173987/pdf/Bookshelf_NBK173987.pdf.
34 34. US Preventive Services Task Force. Final recommendation statement, vitamin supplementation to prevent cancer and CVD: preventive medication, 2014, https://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/vitamin‐supplementation‐to‐prevent‐cancer‐and‐cvd‐counseling#consider, and https://www.uspreventiveservicestaskforce.org/Page/Document/ClinicalSummaryFinal/vitamin‐supplementation‐to‐prevent‐cancer‐and‐cvd‐counseling.
35 35. Kim J, Choi J, Kwon SY, et al. Association of multivitamin and mineral supplementation and risk of cardiovascular disease: a systematic review and meta‐analysis. Circ Cardiovasc Qual Outcomes. 2018; 11:e004224, https://doi.org/10.1161/CIRCOUTCOMES.117.004224.
36 36. Haslam A, Prasad V. Multivitamins do not reduce cardiovascular disease and mortality and should not be taken for this purpose: how do we know that? Circ Cardiovasc Qual Outcomes. 2018; 11:e004886, https://doi.org/10.1161/CIRCOUTCOMES.118.004886, https://www.ahajournals.org/doi/pdf/10.1161/CIRCOUTCOMES.118.004886.
37 37. Schwingshackl L, Boeing H, Stelmach‐Mardas M, et al. Dietary supplements and
